| 1 | English French  Notes   Complete/Exclude | 
|---|
| 2 | ] New order(s) placed. | 
|---|
| 3 | ] New DC order(s) placed. | 
|---|
| 4 | Abnormal labs - [ | 
|---|
| 5 | Abnormal lab: | 
|---|
| 6 | Order requires electronic signature. | 
|---|
| 7 | ] Order placed: | 
|---|
| 8 | ] Result available: | 
|---|
| 9 | Procedure uses non-barium contrast media - abnormal biochem result: | 
|---|
| 10 | Recent Cholecystogram: | 
|---|
| 11 | Patient >65. Renal Results: | 
|---|
| 12 | Missing Labs for Angiogram: | 
|---|
| 13 | Patient allergic to contrast medias: | 
|---|
| 14 | Recent Barium study: | 
|---|
| 15 | WBC < 3.0 and/or ANC < 1.5 - pharmacy cannot fill clozapine order. Most recent results - | 
|---|
| 16 | Clozapine orders require a CBC/Diff within past 7 days.  Please order CBC/Diff with WBC and ANC immediately.  Most recent results - | 
|---|
| 17 | Most recent results - | 
|---|
| 18 | WBC between 3.0 and 3.5 with ANC >= 1.5 - please repeat CBC/Diff including WBC and ANC immediately and twice weekly.  Most recent results - | 
|---|
| 19 | Clozapine - most recent results - | 
|---|
| 20 | Aminoglycoside - est. CrCl: | 
|---|
| 21 | Patient may be | 
|---|
| 22 | Est. CrCl: | 
|---|
| 23 | ordered - adjust diet accordingly. | 
|---|
| 24 | Procedure uses non-barium contrast media and patient is taking glucophage. | 
|---|
| 25 | Potential polypharmacy - patient currently receiving | 
|---|
| 26 | Labs resulted - [ | 
|---|
| 27 | Glucophage - Creatinine results: | 
|---|
| 28 | Glucophage - no serum creatinine within past | 
|---|
| 29 | ] Lab threshold exceeded - [ | 
|---|
| 30 | Patient has no allergy assessment. | 
|---|
| 31 | Duplicate opioid medications: | 
|---|
| 32 | When the transport routine encounters locally | 
|---|
| 33 | altered rule data at a site, do you want to: | 
|---|
| 34 | (O)verwrite, (D)isplay, or (A)sk the site ? | 
|---|
| 35 | Locally altered data will be overwritten without asking. | 
|---|
| 36 | Locally altered data will be displayed only. | 
|---|
| 37 | Sites will be asked before locally altered data is overwritten. | 
|---|
| 38 | Enter Patch ID (ex. OR*3*96): | 
|---|
| 39 | OR* | 
|---|
| 40 | v = Package Version. | 
|---|
| 41 | ppp = Patch Number. | 
|---|
| 42 | (Delete after Install of | 
|---|
| 43 | Scanning for old rule transport routines... | 
|---|
| 44 | No old rule transport routines found... | 
|---|
| 45 | These routines will be deleted and overwritten. | 
|---|
| 46 | Do you want to proceed? | 
|---|
| 47 | Old rule transport routines not deleted (^%ZOSF( | 
|---|
| 48 | Not Deleted... | 
|---|
| 49 | Select an | 
|---|
| 50 | ***** Already selected for transport. ***** | 
|---|
| 51 | None Selected for transport | 
|---|
| 52 | Already selected for transport: | 
|---|
| 53 | Press <Enter> to continue... | 
|---|
| 54 | added to list. | 
|---|
| 55 | removed from list. | 
|---|
| 56 | Select a | 
|---|
| 57 | selected for transport. | 
|---|
| 58 | ORDER CHECK | 
|---|
| 59 | OCX MDD | 
|---|
| 60 | unknown lookup error. | 
|---|
| 61 | could not resolve name. | 
|---|
| 62 | End Transport. | 
|---|
| 63 | already existed. | 
|---|
| 64 | record missing... | 
|---|
| 65 | Unresolved subscript. | 
|---|
| 66 | ^DIE filer data error... | 
|---|
| 67 | ...Correct data Filed | 
|---|
| 68 | Rule Transport aborted, version mismatch. | 
|---|
| 69 | Rule Transport Version: |CVER| | 
|---|
| 70 | Order Check Expert System Rule Transporter | 
|---|
| 71 | data filing error | 
|---|
| 72 | Some expert system rules may be incomplete. | 
|---|
| 73 | No data filing errors. | 
|---|
| 74 | Transport Finished... | 
|---|
| 75 | ]  ERROR - RECORD NOT FOUND | 
|---|
| 76 | ACD EXTRACT V10.1 | 
|---|
| 77 | Available record layouts: | 
|---|
| 78 | 1) VAACCR Record Layout Version 10.1 (VA Registry) | 
|---|
| 79 | 2) NAACCR State Record Layout Version 10.1 | 
|---|
| 80 | Select record layout: | 
|---|
| 81 | Select the record layout to use | 
|---|
| 82 | VACCR EXTRACT V10.1 | 
|---|
| 83 | STATE EXTRACT V10.1 | 
|---|
| 84 | DISPLAY/PRINT on-line instructions | 
|---|
| 85 | STATE REPORTING ACOS INFOA | 
|---|
| 86 | PRIMARY ACOS INFO (850) | 
|---|
| 87 | Select start date: | 
|---|
| 88 | Select end date: | 
|---|
| 89 | Analytic cases only | 
|---|
| 90 | Answer 'YES' if you want only analytic cases (CLASS OF CASE 0-2) extracted. | 
|---|
| 91 | Answer  'NO' if you want all cases (analytic and non-analytic) extracted. | 
|---|
| 92 | |Please activate your PC capture program.  The data will be sent| | 
|---|
| 93 | |        in 30 seconds or when you press the return key.        | | 
|---|
| 94 | No records extracted. | 
|---|
| 95 | ACoS Report Print | 
|---|
| 96 | State Extract Print | 
|---|
| 97 | Report Canceled! | 
|---|
| 98 | Report Queued! | 
|---|
| 99 | These are your current settings: | 
|---|
| 100 | Record layout.......................: | 
|---|
| 101 | Facility Identification Number (FIN): | 
|---|
| 102 | State to be extracted...............: | 
|---|
| 103 | Accession Year......................: | 
|---|
| 104 | Start date..........................: | 
|---|
| 105 | End date............................: | 
|---|
| 106 | Analytic cases only.................: | 
|---|
| 107 | Are these settings correct | 
|---|
| 108 | Accession Year: | 
|---|
| 109 | Facility Identification Number (FIN) | 
|---|
| 110 | The site paramaters record is being edited by another user. | 
|---|
| 111 | Press ENTER to Continue or | 
|---|
| 112 | to Quit: | 
|---|
| 113 | Col# | 
|---|
| 114 | Data item | 
|---|
| 115 | Data Value | 
|---|
| 116 | ONC( | 
|---|
| 117 | ICDO-TOPOGRAPHY is not defined | 
|---|
| 118 | .........: Surgery performed | 
|---|
| 119 | .........: Radiation performed | 
|---|
| 120 | The Accession Year is not 1995. | 
|---|
| 121 | The Diagnostic Confirmation code is not 1. | 
|---|
| 122 | The Class of Case code is not 0, 1 or 2. | 
|---|
| 123 | Date DX and/or First Treatment Date not in 1995. | 
|---|
| 124 | Select table | 
|---|
| 125 | This primary does not satisfy the PCE eligibility criteria: | 
|---|
| 126 | Patient Care Evaluation Study of Cancers of the Urinary Bladder | 
|---|
| 127 | ACCESSION/SEQUENCE NUMBER | 
|---|
| 128 | CLASS OF CASE | 
|---|
| 129 | REFERRED FOR TREATMENT TO | 
|---|
| 130 | ZIP AT DIAGNOSIS | 
|---|
| 131 | SPANISH ORIGIN | 
|---|
| 132 | PRIMARY PAYER AT DIAGNOSIS | 
|---|
| 133 | PATIENT HISTORY OF OTHER CANCER | 
|---|
| 134 | FAMILY HISTORY OF CANCER | 
|---|
| 135 | SMOKING HISTORY | 
|---|
| 136 | DURATION OF SMOKING HISTORY | 
|---|
| 137 | DURATION OF SMOKE-FREE HISTORY | 
|---|
| 138 | TABLE I - GENERAL INFORMATION | 
|---|
| 139 | ACCESSION/SEQUENCE NUMBER.....: | 
|---|
| 140 | CLASS OF CASE.................: | 
|---|
| 141 | 300REFERRED FOR TREATMENT TO..... | 
|---|
| 142 | 9ZIP AT DIAGNOSIS.............. | 
|---|
| 143 | DATE OF BIRTH.................: | 
|---|
| 144 | 9SPANISH ORIGIN................ | 
|---|
| 145 | 18PRIMARY PAYER AT DIAGNOSIS.... | 
|---|
| 146 | 301LENGTH OF STAY................ | 
|---|
| 147 | PATIENT HISTORY OF OTHER CANCER: | 
|---|
| 148 | 305  HEAD AND NECK............... | 
|---|
| 149 | FAMILY HISTORY OF CANCER: | 
|---|
| 150 | 314SMOKING HISTORY (PACKS/DAY)... | 
|---|
| 151 | 315DURATION OF SMOKING HISTORY... | 
|---|
| 152 | 316DURATION OF SMOKE-FREE HISTORY | 
|---|
| 153 | GO TO: | 
|---|
| 154 | CLINICAL DETECTION | 
|---|
| 155 | ONSET OF SYMPTOMS | 
|---|
| 156 | DURATION OF SYMPTOMS BEFORE DIAGNOSIS | 
|---|
| 157 | DIAGNOSTIC PROCEDURES | 
|---|
| 158 | DATE OF INITIAL DIAGNOSIS | 
|---|
| 159 | SPECIALTY MAKING DIAGNOSIS | 
|---|
| 160 | PRIMARY SITE (ICD-O-2) | 
|---|
| 161 | HISTOLOGY (ICD-O-2) | 
|---|
| 162 | TABLE II- DIAGNOSTIC INFORMATION | 
|---|
| 163 | CLINICAL DETECTION: | 
|---|
| 164 | 317  GROSS HEMATURIA................ | 
|---|
| 165 | 318  MICROSCOPIC HEMATURIA.......... | 
|---|
| 166 | 319  URINARY FREQUENCY.............. | 
|---|
| 167 | 320  BLADDER IRRITABILITY........... | 
|---|
| 168 | 323ONSET OF SYMPTOMS................ | 
|---|
| 169 | DURATION OF SYMPTOMS (months) BEFORE DIAGNOSIS: | 
|---|
| 170 | 324  GROSS HEMATURIA................ | 
|---|
| 171 | DIAGNOSTIC PROCEDURES: | 
|---|
| 172 | 326  BIMANUAL EXAMINATION OF BLADDER | 
|---|
| 173 | 327  CYSTOSCOPY WITH BIOPSY......... | 
|---|
| 174 | 328  CYSTOSCOPY WITHOUT BIOPSY...... | 
|---|
| 175 | 329  FLOW CYTOMETRY................. | 
|---|
| 176 | 330  INTRAVENOUS PYELOGRAM.......... | 
|---|
| 177 | 331  URINE CYTOLOGY................. | 
|---|
| 178 | DATE OF INITIAL DIAGNOSIS........: | 
|---|
| 179 | 334SPECIALTY MAKING DIAGNOSIS....... | 
|---|
| 180 | PRIMARY SITE (ICD-O-2)...........: | 
|---|
| 181 | HISTOLOGY (ICD-O-2)..............: | 
|---|
| 182 | STAGING PROCEDURES | 
|---|
| 183 | PRESENCE OF HYDRONEPHROSIS | 
|---|
| 184 | TUMOR SIZE (mm) | 
|---|
| 185 | PRESENCE OF MULTIPLE TUMORS | 
|---|
| 186 | REGIONAL NODES EXAMINED | 
|---|
| 187 | REGIONAL NODES POSITIVE | 
|---|
| 188 | SITES OF DISTANT METASTASIS | 
|---|
| 189 | AJCC CLINICAL STAGE (cTNM) | 
|---|
| 190 | AJCC PATHOLOGIC STAGE (pTNM) | 
|---|
| 191 | STAGED BY | 
|---|
| 192 | TABLE III- EXTENT OF DISEASE AND AJCC STAGE | 
|---|
| 193 | STAGING PROCEDURES: | 
|---|
| 194 | 335  ABDOMINAL ULTRASOUND......... | 
|---|
| 195 | 336  BONE IMAGING................. | 
|---|
| 196 | 338  CT CHEST/LUNG................ | 
|---|
| 197 | 339  CT ABDOMEN/PELVIS............ | 
|---|
| 198 | 340  CT OTHER..................... | 
|---|
| 199 | 341  MRI PELVIS/ABDOMEN........... | 
|---|
| 200 | 342  MRI OTHER.................... | 
|---|
| 201 | 344PRESENCE OF HYDRONEPHROSIS..... | 
|---|
| 202 | 29TUMOR SIZE (mm)................ | 
|---|
| 203 | 345PRESENCE OF MULTIPLE TUMORS.... | 
|---|
| 204 | 33REGIONAL NODES EXAMINED........ | 
|---|
| 205 | 32REGIONAL NODES POSITIVE........ | 
|---|
| 206 | SITES OF DISTANT METASTASIS: | 
|---|
| 207 | 34  SITE OF DISTANT METASTASIS #1 | 
|---|
| 208 | SITE OF DISTANT METASTASIS #2: None | 
|---|
| 209 | SITE OF DISTANT METASTASIS #3: None | 
|---|
| 210 | 34.1  SITE OF DISTANT METASTASIS #2 | 
|---|
| 211 | 34.2  SITE OF DISTANT METASTASIS #3 | 
|---|
| 212 | AJCC CLINICAL STAGE (cTNM): | 
|---|
| 213 | 38AJCC STAGE..................... | 
|---|
| 214 | AJCC PATHOLOGIC STAGE (pTNM): | 
|---|
| 215 | 88AJCC STAGE..................... | 
|---|
| 216 | STAGED BY: | 
|---|
| 217 | 19  CLINICAL STAGE.................... | 
|---|
| 218 | 89  PATHOLOGIC STAGE.................. | 
|---|
| 219 | DATE OF INITIAL TREATMENT | 
|---|
| 220 | PROTOCOL ELIGIBILITY STATUS | 
|---|
| 221 | MANAGING PHYSICIANS | 
|---|
| 222 | RADIATION THERAPY | 
|---|
| 223 | TABLE IV - FIRST COURSE OF TREATMENT | 
|---|
| 224 | DATE OF INITIAL TREATMENT...........: | 
|---|
| 225 | 346PROTOCOL ELIGIBILITY STATUS......... | 
|---|
| 226 | MANAGING PHYSICIANS: | 
|---|
| 227 | 347  PRIMARY PHYSICIAN................. | 
|---|
| 228 | 348  SECONDARY PHYSICIAN............... | 
|---|
| 229 | SURGERY: | 
|---|
| 230 | DATE OF SURGERY...................: | 
|---|
| 231 | TYPE OF SURGERY...................: | 
|---|
| 232 | TUMOR RESECTION DURING TURB.......: Not applicable | 
|---|
| 233 | 349  TUMOR RESECTION DURING TURB....... | 
|---|
| 234 | TYPE OF URINARY DIVERSION.........: Not applicable | 
|---|
| 235 | 350  TYPE OF URINARY DIVERSION......... | 
|---|
| 236 | PELVIC LYMPH NODE DISSECTION......: Not applicable | 
|---|
| 237 | 351  PELVIC LYMPH NODE DISSECTION...... | 
|---|
| 238 | SURGICAL COMPLICATIONS: | 
|---|
| 239 | BLEEDING REQUIRING TRANSFUSION..: No | 
|---|
| 240 | DEEP VENOUS THROMBOSIS..........: No | 
|---|
| 241 | MYOCARDIAL INFARCTION/ARRHYTHMIA: No | 
|---|
| 242 | PELVIC ABSCESS..................: No | 
|---|
| 243 | PNEUMONIA REQUIRING ANTIBIOTICS.: No | 
|---|
| 244 | POST-OPERATIVE DEATH (30 DAYS)..: No | 
|---|
| 245 | PULMONARY EMBOLISM/THROMBOSIS...: No | 
|---|
| 246 | 352    BLEEDING REQUIRING TRANSFUSION.. | 
|---|
| 247 | 353    DEEP VENOUS THROMBOSIS.......... | 
|---|
| 248 | 354    MYOCARDIAL INFARCTION/ARRHYTHMIA | 
|---|
| 249 | 355    PELVIC ABSCESS.................. | 
|---|
| 250 | 356    PNEUMONIA REQUIRING ANTIBIOTICS. | 
|---|
| 251 | 357    POST-OPERATIVE DEATH (30 DAYS).. | 
|---|
| 252 | 358    PULMONARY EMBOLISM/THROMBOSIS... | 
|---|
| 253 | RADIATION THERAPY: | 
|---|
| 254 | RADIATION THERAPY.................: | 
|---|
| 255 | DATE RADIATION THERAPY STARTED....: | 
|---|
| 256 | DATE RADIATION THERAPY ENDED......: 00/00/0000 | 
|---|
| 257 | TOTAL RAD (cGy/rad) DOSE..........: 00000 | 
|---|
| 258 | REGIONAL TREATMENT MODALITY.......: No radiation therapy | 
|---|
| 259 | RADIATION COMPLICATIONS: | 
|---|
| 260 | URINARY INCONTINENCE............: Not applicable | 
|---|
| 261 | HEMATURIA.......................: Not applicable | 
|---|
| 262 | RADIATION BOWEL INJURY..........: Not applicable | 
|---|
| 263 | DATE RADIATION THERAPY ENDED......: 99/99/9999 | 
|---|
| 264 | TOTAL RAD (cGy/rad) DOSE..........: 99999 | 
|---|
| 265 | REGIONAL TREATMENT MODALITY.......: Unknown | 
|---|
| 266 | URINARY INCONTINENCE............: Unknown | 
|---|
| 267 | RADIATION BOWEL INJURY..........: Unknown | 
|---|
| 268 | 361  DATE RADIATION THERAPY ENDED...... | 
|---|
| 269 | 362  TOTAL RAD (cGy/rad) DOSE.......... | 
|---|
| 270 | 363  REGIONAL TREATMENT MODALITY....... | 
|---|
| 271 | 364    URINARY INCONTINENCE............ | 
|---|
| 272 | 366    RADIATION BOWEL INJURY.......... | 
|---|
| 273 | CHEMOTHERAPY: | 
|---|
| 274 | DATE CHEMOTHERAPY STARTED.........: | 
|---|
| 275 | DATE CHEMOTHERAPY ENDED...........: 00/00/0000 | 
|---|
| 276 | ROUTE CHEMOTHERAPY ADMINISTERED...: No chemotherapy | 
|---|
| 277 | TYPES OF AGENTS ADMINISTERED: | 
|---|
| 278 | ADRIAMYCIN......: None      IFOSFAMIDE......: None | 
|---|
| 279 | CARBOPLATINUM...: None      METHOTREXATE....: None | 
|---|
| 280 | CISPLATIN.......: None      TAXOL...........: None | 
|---|
| 281 | CYCLOPHOSPHAMIDE: None      THIOTEPA........: None | 
|---|
| 282 | 5-FLUOROURACIL..: None      VINBLASTINE.....: None | 
|---|
| 283 | GALLIUM NITRATE.: None      OTHER...........: None | 
|---|
| 284 | INDICATION FOR ADMIN OF AGENTS....: No agents administered, NA | 
|---|
| 285 | REASON CHEMOTHERAPY STOPPED.......: Treatment completed, NA | 
|---|
| 286 | DATE CHEMOTHERAPY ENDED...........: 99/99/9999 | 
|---|
| 287 | ROUTE CHEMOTHERAPY ADMINISTERED...: Unknown | 
|---|
| 288 | ADRIAMYCIN......: Unknown   IFOSFAMIDE......: Unknown | 
|---|
| 289 | CARBOPLATINUM...: Unknown   METHOTREXATE....: Unknown | 
|---|
| 290 | CISPLATIN.......: Unknown   TAXOL...........: Unknown | 
|---|
| 291 | CYCLOPHOSPHAMIDE: Unknown   THIOTEPA........: Unknown | 
|---|
| 292 | 5-FLUOROURACIL..: Unknown   VINBLASTINE.....: Unknown | 
|---|
| 293 | GALLIUM NITRATE.: Unknown   OTHER...........: Unknown | 
|---|
| 294 | INDICATION FOR ADMIN OF AGENTS....: Unknown | 
|---|
| 295 | REASON CHEMOTHERAPY STOPPED.......: Unknown | 
|---|
| 296 | 367  DATE CHEMOTHERAPY ENDED........... | 
|---|
| 297 | 368  ROUTE CHEMOTHERAPY ADMINISTERED... | 
|---|
| 298 | 374    GALLIUM NITRATE................. | 
|---|
| 299 | 380    OTHER AGENT..................... | 
|---|
| 300 | 381  INDICATION FOR ADMIN OF AGENTS.... | 
|---|
| 301 | 382  REASON CHEMOTHERAPY STOPPED....... | 
|---|
| 302 | IMMUNOTHERAPY: | 
|---|
| 303 | ####################    ####################    #################### | 
|---|
| 304 | ####################    ####################    #################### | 
|---|
| 305 | ####################    ####################    #################### | 
|---|
| 306 | ####################    ####################    #################### | 
|---|
| 307 | ####################    ####################    #################### | 
|---|